{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:56:24Z","timestamp":1789718184824,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"12","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s11427-015-4965-6","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T16:10:02Z","timestamp":1447863002000},"page":"1202-1208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["An overview of chronic myeloid leukemia and its animal models"],"prefix":"10.1007","volume":"58","author":[{"given":"WeiXu","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoHui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YiYue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WenQing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,18]]},"reference":[{"key":"4965_CR1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ajh.23691","volume":"89","author":"E Jabbour","year":"2014","unstructured":"Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management. Am J Hematol, 2014, 89: 547\u2013556","journal-title":"Am J Hematol"},{"key":"4965_CR2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s004320050228","volume":"124","author":"G Pasternak","year":"1998","unstructured":"Pasternak G, Hochhaus A, Schultheis B, Hehlmann R. Chronic myelogenous leukemia: molecular and cellular aspects. J Cancer Res Clin Oncol, 1998, 124: 643\u2013660","journal-title":"J Cancer Res Clin Oncol"},{"key":"4965_CR3","first-page":"1497","volume":"132","author":"DA Hungerford","year":"1960","unstructured":"Hungerford DA, Nowell PC. A minute chromosome in human granulocytic leukemia. Science, 1960, 132: 1497\u20131497","journal-title":"Science"},{"key":"4965_CR4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0014-4827(70)90362-9","volume":"63","author":"T Caspersson","year":"1970","unstructured":"Caspersson T, Gahrton G, Lindsten J, Zech L. Identification of the Philadelphia chromosome as a number 22 by quinacrine mustard fluorescence analysis. Exp Cell Res, 1970, 63: 238\u2013240","journal-title":"Exp Cell Res"},{"key":"4965_CR5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley JD. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature, 1973, 243: 290\u2013293","journal-title":"Nature"},{"key":"4965_CR6","first-page":"109","volume":"16","author":"JD Rowley","year":"1973","unstructured":"Rowley JD. Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia. Ann Genet, 1973, 16: 109\u2013112","journal-title":"Ann Genet"},{"key":"4965_CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0092-8674(84)90077-1","volume":"36","author":"J Groffen","year":"1984","unstructured":"Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell, 1984, 36: 93\u201399","journal-title":"Cell"},{"key":"4965_CR8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/0003-4819-138-10-200305200-00010","volume":"138","author":"R Kurzrock","year":"2003","unstructured":"Kurzrock R, Kantarjian HM, Druker BJ, Talpaz M. Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics. Ann Intern Med, 2003, 138: 819\u2013830","journal-title":"Ann Intern Med"},{"key":"4965_CR9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/01.JAA.0000442706.18470.9a","volume":"27","author":"JM Gore","year":"2014","unstructured":"Gore JM. Chronic myeloid leukemia and chronic lymphocytic leukemia. JAAPA, 2014, 27: 45\u201346","journal-title":"JAAPA"},{"key":"4965_CR10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1272\/jnms.73.178","volume":"73","author":"K Inokuchi","year":"2006","unstructured":"Inokuchi K. Chronic myelogenous leukemia: from molecular biology to clinical aspects and novel targeted therapies. J Nippon Med Sch, 2006, 73: 178\u2013192","journal-title":"J Nippon Med Sch"},{"key":"4965_CR11","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/MCB.9.7.2798","volume":"9","author":"IK Hariharan","year":"1989","unstructured":"Hariharan IK, Harris AW, Crawford M, Abud H, Webb E, Cory S, Adams JM. A bcr-v-abl oncogene induces lymphomas in transgenic mice. Mol Cell Biol, 1989, 9: 2798\u20132805","journal-title":"Mol Cell Biol"},{"key":"4965_CR12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/344251a0","volume":"344","author":"N Heisterkamp","year":"1990","unstructured":"Heisterkamp N, Jenster G, Ten HJ, Zovich D, Pattengale PK, Groffen J. Acute leukaemia in bcr\/abl transgenic mice. Nature, 1990, 344: 251\u2013253","journal-title":"Nature"},{"key":"4965_CR13","first-page":"4534","volume":"52","author":"JW Voncken","year":"1992","unstructured":"Voncken JW, Griffiths S, Greaves MF, Pattengale PK, Heisterkamp N, Groffen J. Restricted oncogenicity of BCR\/ABL p190 in transgenic mice. Cancer Res, 1992, 52: 4534\u20134539","journal-title":"Cancer Res"},{"key":"4965_CR14","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1182\/blood.V86.12.4603.bloodjournal86124603","volume":"86","author":"JW Voncken","year":"1995","unstructured":"Voncken JW, Kaartinen V, Pattengale PK, Germeraad WT, Groffen J, Heisterkamp N. BCR\/ABL P210 and P190 cause distinct leukemia in transgenic mice. Blood, 1995, 86: 4603\u20134611","journal-title":"Blood"},{"key":"4965_CR15","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1182\/blood.V85.10.2853.bloodjournal85102853","volume":"85","author":"H Honda","year":"1995","unstructured":"Honda H, Fujii T, Takatoku M, Mano H, Witte ON, Yazaki Y, Hirai H. Expression of p210bcr\/abl by metallothionein promoter induced T-cell leukemia in transgenic mice. Blood, 1995, 85: 2853\u20132861","journal-title":"Blood"},{"key":"4965_CR16","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V91.6.2067","volume":"91","author":"H Honda","year":"1998","unstructured":"Honda H, Oda H, Suzuki T, Takahashi T, Witte ON, Ozawa K, Ishikawa T, Yazaki Y, Hirai H. Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr\/abl: a novel transgenic model for human Ph1-positive leukemias. Blood, 1998, 91: 2067\u20132075","journal-title":"Blood"},{"key":"4965_CR17","doi-asserted-by":"crossref","first-page":"10002","DOI":"10.1073\/pnas.1633833100","volume":"100","author":"S Jaiswal","year":"2003","unstructured":"Jaiswal S, Traver D, Miyamoto T, Akashi K, Lagasse E, Weissman IL. Expression of BCR\/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias. Proc Natl Acad Sci USA, 2003, 100: 10002\u201310007","journal-title":"Proc Natl Acad Sci USA"},{"key":"4965_CR18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/emboj.2008.253","volume":"28","author":"M Perez-Caro","year":"2009","unstructured":"Perez-Caro M, Cobaleda C, Gonzalez-Herrero I, Vicente-Duenas C, Bermejo-Rodriguez C, Sanchez-Beato M, Orfao A, Pintado B, Flores T, Sanchez-Martin M, Jimenez R, Piris MA, Sanchez-Garcia I. Cancer induction by restriction of oncogene expression to the stem cell compartment. Embo J, 2009, 28: 8\u201320","journal-title":"Embo J"},{"key":"4965_CR19","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1073\/pnas.89.12.5547","volume":"89","author":"M Gossen","year":"1992","unstructured":"Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA, 1992, 89: 5547\u20135551","journal-title":"Proc Natl Acad Sci USA"},{"key":"4965_CR20","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1126\/science.7792603","volume":"268","author":"M Gossen","year":"1995","unstructured":"Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science, 1995, 268: 1766\u20131769","journal-title":"Science"},{"key":"4965_CR21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/71691","volume":"24","author":"CS Huettner","year":"2000","unstructured":"Huettner CS, Zhang P, Van Etten RA, Tenen DG. Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat Genet, 2000, 24: 57\u201360","journal-title":"Nat Genet"},{"key":"4965_CR22","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1182\/blood-2002-02-0355","volume":"100","author":"HS Radomska","year":"2002","unstructured":"Radomska HS, Gonzalez DA, Okuno Y, Iwasaki H, Nagy A, Akashi K, Tenen DG, Huettner CS. Transgenic targeting with regulatory elements of the human CD34 gene. Blood, 2002, 100: 4410\u20134419","journal-title":"Blood"},{"key":"4965_CR23","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1182\/blood-2003-03-0768","volume":"102","author":"CS Huettner","year":"2003","unstructured":"Huettner CS, Koschmieder S, Iwasaki H, Iwasaki-Arai J, Radomska HS, Akashi K, Tenen DG. Inducible expression of BCR\/ABL using human CD34 regulatory elements results in a megakaryocytic myeloproliferative syndrome. Blood, 2003, 102: 3363\u20133370","journal-title":"Blood"},{"key":"4965_CR24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1182\/blood-2003-12-4369","volume":"105","author":"S Koschmieder","year":"2005","unstructured":"Koschmieder S, Gottgens B, Zhang P, Iwasaki-Arai J, Akashi K, Kutok JL, Dayaram T, Geary K, Green AR, Tenen DG, Huettner CS. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. Blood, 2005, 105: 324\u2013334","journal-title":"Blood"},{"key":"4965_CR25","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1182\/blood.V90.6.2168","volume":"90","author":"A Castellanos","year":"1997","unstructured":"Castellanos A, Pintado B, Weruaga E, Arevalo R, Lopez A, Orfao A, Sanchez-Garcia I. A BCR-ABL(p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product. Blood, 1997, 90: 2168\u20132174","journal-title":"Blood"},{"key":"4965_CR26","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1038\/sj.onc.1204374","volume":"20","author":"DG Peters","year":"2001","unstructured":"Peters DG, Klucher KM, Perlingeiro RC, Dessain SK, Koh EY, Daley GQ. Autocrine and paracrine effects of an ES-cell derived, BCR\/ABL-transformed hematopoietic cell line that induces leukemia in mice. Oncogene, 2001, 20: 2636\u20132646","journal-title":"Oncogene"},{"key":"4965_CR27","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","volume":"247","author":"GQ Daley","year":"1990","unstructured":"Daley GQ, Van Etten RA, Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome. Science, 1990, 247: 824\u2013830","journal-title":"Science"},{"key":"4965_CR28","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1073\/pnas.87.17.6649","volume":"87","author":"MA Kelliher","year":"1990","unstructured":"Kelliher MA, McLaughlin J, Witte ON, Rosenberg N. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR\/ABL. Proc Natl Acad Sci USA, 1990, 87: 6649\u20136653","journal-title":"Proc Natl Acad Sci USA"},{"key":"4965_CR29","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V92.10.3780","volume":"92","author":"WS Pear","year":"1998","unstructured":"Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC, Pendergast AM, Bronson R, Aster JC, Scott ML, Baltimore D. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr\/abl-transduced bone marrow. Blood, 1998, 92: 3780\u20133792","journal-title":"Blood"},{"key":"4965_CR30","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1084\/jem.189.9.1399","volume":"189","author":"S Li","year":"1999","unstructured":"Li S, Ilaria R J, Million RP, Daley GQ, Van Etten RA. The P190, P210, and P230 forms of the BCR\/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med, 1999, 189: 1399\u20131412","journal-title":"J Exp Med"},{"key":"4965_CR31","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood.V92.10.3829","volume":"92","author":"X Zhang","year":"1998","unstructured":"Zhang X, Ren R. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte- macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. Blood, 1998, 92: 3829\u20133840","journal-title":"Blood"},{"key":"4965_CR32","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1182\/blood.V98.9.2808","volume":"98","author":"NC Wolff","year":"2001","unstructured":"Wolff NC, Ilaria RJ. Establishment of a murine model for therapy- treated chronic myelogenous leukemia using the tyrosine kinase inhibitor STI571. Blood, 2001, 98: 2808\u20132816","journal-title":"Blood"},{"key":"4965_CR33","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood.V99.8.2957","volume":"99","author":"Y He","year":"2002","unstructured":"He Y, Wertheim JA, Xu L, Miller JP, Karnell FG, Choi JK, Ren R, Pear WS. The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr\/abl. Blood, 2002, 99: 2957\u20132968","journal-title":"Blood"},{"key":"4965_CR34","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V96.2.664","volume":"96","author":"RP Million","year":"2000","unstructured":"Million RP, Van Etten RA. The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr\/Abl tyrosine kinase. Blood, 2000, 96: 664\u2013670","journal-title":"Blood"},{"key":"4965_CR35","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/MCB.21.3.840-853.2001","volume":"21","author":"X Zhang","year":"2001","unstructured":"Zhang X, Subrahmanyam R, Wong R, Gross AW, Ren R. The NH2-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl. Mol Cell Biol, 2001, 21: 840\u2013853","journal-title":"Mol Cell Biol"},{"key":"4965_CR36","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1182\/blood-2005-10-4110","volume":"107","author":"D Ye","year":"2006","unstructured":"Ye D, Wolff N, Li L, Zhang S, Ilaria RJ. STAT5 signaling is required for the efficient induction and maintenance of CML in mice. Blood, 2006, 107: 4917\u20134925","journal-title":"Blood"},{"key":"4965_CR37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/emmm.201000062","volume":"2","author":"A Hoelbl","year":"2010","unstructured":"Hoelbl A, Schuster C, Kovacic B, Zhu B, Wickre M, Hoelzl MA, Fajmann S, Grebien F, Warsch W, Stengl G, Hennighausen L, Poli V, Beug H, Moriggl R, Sexl V. Stat5 is indispensable for the maintenance of bcr\/abl-positive leukaemia. Embo Mol Med, 2010, 2: 98\u2013110","journal-title":"Embo Mol Med"},{"key":"4965_CR38","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1182\/blood-2011-12-397554","volume":"119","author":"C Walz","year":"2012","unstructured":"Walz C, Ahmed W, Lazarides K, Betancur M, Patel N, Hennighausen L, Zaleskas VM, Van Etten RA. Essential role for Stat5a\/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2(V617F) in mice. Blood, 2012, 119: 3550\u20133560","journal-title":"Blood"},{"key":"4965_CR39","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1073\/pnas.0711824105","volume":"105","author":"SJ Zhang","year":"2008","unstructured":"Zhang SJ, Ma LY, Huang QH, Li G, Gu BW, Gao XD, Shi JY, Wang YY, Gao L, Cai X, Ren RB, Zhu J, Chen Z, Chen SJ. Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc Natl Acad Sci USA, 2008, 105: 2076\u20132081","journal-title":"Proc Natl Acad Sci USA"},{"key":"4965_CR40","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/ijc.28427","volume":"134","author":"RM Eit El","year":"2014","unstructured":"El Eit RM, Iskandarani AN, Saliba JL, Jabbour MN, Mahfouz RA, Bitar NM, Ayoubi HR, Zaatari GS, Mahon FX, De The HB, Bazarbachi AA, Nasr RR. Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha. Int J Cancer, 2014, 134: 988\u2013996","journal-title":"Int J Cancer"},{"key":"4965_CR41","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1073\/pnas.0602402103","volume":"103","author":"H d Wendel","year":"2006","unstructured":"Wendel HG, de Stanchina E, Cepero E, Ray S, Emig M, Fridman JS, Veach DR, Bornmann WG, Clarkson B, Mc Combie WR, Kogan SC, Hochhaus A, Lowe SW. Loss of p53 impedes the antileukemic response to BCR-ABL inhibition. Proc Natl Acad Sci USA, 2006, 103: 7444\u20137449","journal-title":"Proc Natl Acad Sci USA"},{"key":"4965_CR42","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood-2010-10-309583","volume":"118","author":"C Albers","year":"2011","unstructured":"Albers C, Illert AL, Miething C, Leischner H, Thiede M, Peschel C, Duyster J. An RNAi-based system for loss-of-function analysis identifies Raf1 as a crucial mediator of BCR-ABL-driven leukemogenesis. Blood, 2011, 118: 2200\u20132210","journal-title":"Blood"},{"key":"4965_CR43","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/leu.2013.40","volume":"27","author":"LC Gillis","year":"2013","unstructured":"Gillis LC, Berry DM, Minden MD, Mc Glade CJ, Barber DL. Gads (Grb2-related adaptor downstream of Shc) is required for BCR-ABL-mediated lymphoid leukemia. Leukemia, 2013, 27: 1666\u20131676","journal-title":"Leukemia"},{"key":"4965_CR44","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood.V79.8.2089.2089","volume":"79","author":"CL Sawyers","year":"1992","unstructured":"Sawyers CL, Gishizky ML, Quan S, Golde DW, Witte ON. Propagation of human blastic myeloid leukemias in the SCID mouse. Blood, 1992, 79: 2089\u20132098","journal-title":"Blood"},{"key":"4965_CR45","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1182\/blood.V87.4.1539.bloodjournal8741539","volume":"87","author":"C Sirard","year":"1996","unstructured":"Sirard C, Lapidot T, Vormoor J, Cashman JD, Doedens M, Murdoch B, Jamal N, Messner H, Addey L, Minden M, Laraya P, Keating A, Eaves A, Lansdorp PM, Eaves CJ, Dick JE. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood, 1996, 87: 1539\u20131548","journal-title":"Blood"},{"key":"4965_CR46","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1182\/blood.V91.7.2406","volume":"91","author":"JC Wang","year":"1998","unstructured":"Wang JC, Lapidot T, Cashman JD, Doedens M, Addy L, Sutherland DR, Nayar R, Laraya P, Minden M, Keating A, Eaves AC, Eaves CJ, Dick JE. High level engraftment of NOD\/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood, 1998, 91: 2406\u20132414","journal-title":"Blood"},{"key":"4965_CR47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-4939-2297-0_12","volume":"1267","author":"C Schneckenleithner","year":"2015","unstructured":"Schneckenleithner C, Hoelbl-Kovacic A, Sexl V. Modeling BCR\/ABL-driven malignancies in the mouse. Methods Mol Biol, 2015, 1267: 263\u2013282","journal-title":"Methods Mol Biol"},{"key":"4965_CR48","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1182\/blood-2006-05-024075","volume":"108","author":"SA Renshaw","year":"2006","unstructured":"Renshaw SA, Loynes CA, Trushell DM, Elworthy S, Ingham PW, Whyte MK. A transgenic zebrafish model of neutrophilic inflammation. Blood, 2006, 108: 3976\u20133978","journal-title":"Blood"},{"key":"4965_CR49","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1189\/jlb.0506346","volume":"80","author":"JR Mathias","year":"2006","unstructured":"Mathias JR, Perrin BJ, Liu TX, Kanki J, Look AT, Huttenlocher A. Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish. J Leukoc Biol, 2006, 80: 1281\u20131288","journal-title":"J Leukoc Biol"},{"key":"4965_CR50","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood-2005-02-0717","volume":"106","author":"F Rosenbauer","year":"2005","unstructured":"Rosenbauer F, Koschmieder S, Steidl U, Tenen DG. Effect of transcription- factor concentrations on leukemic stem cells. Blood, 2005, 106: 1519\u20131524","journal-title":"Blood"},{"key":"4965_CR51","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2141.2008.07362.x","volume":"143","author":"J Zhuravleva","year":"2008","unstructured":"Zhuravleva J, Paggetti J, Martin L, Hammann A, Solary E, Bastie JN, Delva L. MOZ\/TIF2-induced acute myeloid leukaemia in transgenic fish. Br J Haematol, 2008, 143: 378\u2013382","journal-title":"Br J Haematol"},{"key":"4965_CR52","doi-asserted-by":"crossref","first-page":"e59070","DOI":"10.1371\/journal.pone.0059070","volume":"8","author":"LJ Shen","year":"2013","unstructured":"Shen LJ, Chen FY, Zhang Y, Cao LF, Kuang Y, Zhong M, Wang T, Zhong H. MYCN transgenic zebrafish model with the characterization of acute myeloid leukemia and altered hematopoiesis. PLoS One, 2013, 8: e59070","journal-title":"PLoS One"},{"key":"4965_CR53","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.exphem.2004.10.019","volume":"33","author":"SM Onnebo","year":"2005","unstructured":"Onnebo SM, Condron MM, McPhee DO, Lieschke GJ, Ward AC. Hematopoietic perturbation in zebrafish expressing a tel-jak2a fusion. Exp Hematol, 2005, 33: 182\u2013188","journal-title":"Exp Hematol"},{"key":"4965_CR54","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3324\/haematol.2012.064659","volume":"97","author":"SM Onnebo","year":"2012","unstructured":"Onnebo SM, Rasighaemi P, Kumar J, Liongue C, Ward AC. Alternative TEL-JAK2 fusions associated with T-cell acute lymphoblastic leukemia and atypical chronic myelogenous leukemia dissected in zebrafish. Haematologica, 2012, 97: 1895\u20131903","journal-title":"Haematologica"},{"key":"4965_CR55","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/embo-reports\/kvd027","volume":"1","author":"F Buchholz","year":"2000","unstructured":"Buchholz F, Refaeli Y, Trumpp A, Bishop JM. Inducible chromosomal translocation of AML1 and ETO genes through Cre\/loxPmediated recombination in the mouse. Embo Rep, 2000, 1: 133\u2013139","journal-title":"Embo Rep"},{"key":"4965_CR56","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1101\/gr.147314.112","volume":"23","author":"M Piganeau","year":"2013","unstructured":"Piganeau M, Ghezraoui H, De Cian A, Guittat L, Tomishima M, Perrouault L, Rene O, Katibah GE, Zhang L, Holmes MC, Doyon Y, Concordet JP, Giovannangeli C, Jasin M, Brunet E. Cancer translocations in human cells induced by zinc finger and TALE nucleases. Genome Res, 2013, 23: 1182\u20131193","journal-title":"Genome Res"},{"key":"4965_CR57","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11427-014-4670-x","volume":"57","author":"L Zhang","year":"2014","unstructured":"Zhang L, Zhou Q. CRISPR\/Cas technology: a revolutionary approach for genome engineering. Sci China Life Sci, 2014, 57: 639\u2013640","journal-title":"Sci China Life Sci"},{"key":"4965_CR58","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1038\/ncomms4964","volume":"5","author":"R Torres","year":"2014","unstructured":"Torres R, Martin MC, Garcia A, Cigudosa JC, Ramirez JC, Rodriguez- Perales S. Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system. Nat Commun, 2014, 5: 3964","journal-title":"Nat Commun"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-015-4965-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T14:43:42Z","timestamp":1599835422000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11427-015-4965-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,18]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["4965"],"URL":"https:\/\/doi.org\/10.1007\/s11427-015-4965-6","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,18]]}}}